Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D007531:Isoflurophate / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009388:Neostigmine / Q000494:pharmacology; D010095:Oxotremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D010830:Physostigmine / Q000494:pharmacology / Q000633:toxicity; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D007531:Isoflurophate; D009388:Neostigmine; D010095:Oxotremorine; D001285:Atropine; D010830:Physostigmine